Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study

We evaluated the psychometric properties of the Spanish version of the European Organization for Research and Treatment of Multiple Myeloma (MM) specific quality-of-life (QoL) questionnaire module (QLQ-MY20) in relapsed/refractory MM (RRMM) patients. This was an observational, cross-sectional, multi...

ver descrição completa

Detalhes bibliográficos
Autores: Rosiñol, Laura, Montes, Carmen, Bustamante, Gabriela, Garzón, Sebastián, González García, María-Esther, Pérez Persona, Ernesto, González-Calle, Verónica, Sirvent Auzmendi, Maialen, Arguiñano, José M., González Montes, Yolanda, Ríos Tamayo, Rafael, Miguel Llorente, Dunia de, Palomera, Luis, Sampol, Antonia, Couto, María del Carmen, Grande, Marta, Fernández-Nistal, Alonso, Naves, Andrea, Ocio, Enrique M.
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2023
País:España
Recursos:Consejo Superior de Investigaciones Científicas (CSIC)
Repositório:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/346960
Acesso em linha:http://hdl.handle.net/10261/346960
Access Level:Acceso aberto
Palavra-chave:Multiple myeloma
Relapsed/refractory multiple myeloma
Quality of life
Health‐related quality of life
EORTC QLQ-MY20 assessment
Burden of the disease
id ES_fc6eb2d0548e8d7aa032b4d44e1089a7
oai_identifier_str oai:digital.csic.es:10261/346960
network_acronym_str ES
network_name_str España
repository_id_str
spelling Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa studyRosiñol, LauraMontes, CarmenBustamante, GabrielaGarzón, SebastiánGonzález García, María-EstherPérez Persona, ErnestoGonzález-Calle, VerónicaSirvent Auzmendi, MaialenArguiñano, José M.González Montes, YolandaRíos Tamayo, RafaelMiguel Llorente, Dunia dePalomera, LuisSampol, AntoniaCouto, María del CarmenGrande, MartaFernández-Nistal, AlonsoNaves, AndreaOcio, Enrique M.Multiple myelomaRelapsed/refractory multiple myelomaQuality of lifeHealth‐related quality of lifeEORTC QLQ-MY20 assessmentBurden of the diseaseWe evaluated the psychometric properties of the Spanish version of the European Organization for Research and Treatment of Multiple Myeloma (MM) specific quality-of-life (QoL) questionnaire module (QLQ-MY20) in relapsed/refractory MM (RRMM) patients. This was an observational, cross-sectional, multicenter study using EORTC QLQ-C30 and QLQ-MY20 in RRMM patients (ClinicalTrials.gov ID NCT03188536). We assessed the non-response rate, ceiling/floor effects, internal consistency, test-retest reliability, and validity. The study included 276 patients (53.3% males, mean [SD] age of 67.4 [10.5] years). The EORTC QLQ-MY20 showed a low non-response rate, very low ceiling and floor effects, and good internal consistency. The test-retest reliability assessment revealed good temporary stability, the construct validity analysis stated four main factors similar to the ones of the original version, and the criterion validity assessment showed no differences between groups. In conclusion, the Spanish version of EORTC QLQ-MY20 is a reliable and valid tool for assessing QoL in RRMM patients.The study was sponsored and funded by Takeda Farmacéutica España.Peer reviewedTaylor & FrancisTakeda Pharmaceutical CompanyConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]2024202420232024info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10261/346960reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)InglésThe underlying dataset has been published as supplementary material of the article in the publisher platform at 10.1080/10428194.2023.2240922http://dx.doi.org/10.1080/10428194.2023.2240922Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/3469602026-05-22T06:33:51Z
dc.title.none.fl_str_mv Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study
title Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study
spellingShingle Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study
Rosiñol, Laura
Multiple myeloma
Relapsed/refractory multiple myeloma
Quality of life
Health‐related quality of life
EORTC QLQ-MY20 assessment
Burden of the disease
title_short Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study
title_full Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study
title_fullStr Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study
title_full_unstemmed Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study
title_sort Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study
dc.creator.none.fl_str_mv Rosiñol, Laura
Montes, Carmen
Bustamante, Gabriela
Garzón, Sebastián
González García, María-Esther
Pérez Persona, Ernesto
González-Calle, Verónica
Sirvent Auzmendi, Maialen
Arguiñano, José M.
González Montes, Yolanda
Ríos Tamayo, Rafael
Miguel Llorente, Dunia de
Palomera, Luis
Sampol, Antonia
Couto, María del Carmen
Grande, Marta
Fernández-Nistal, Alonso
Naves, Andrea
Ocio, Enrique M.
author Rosiñol, Laura
author_facet Rosiñol, Laura
Montes, Carmen
Bustamante, Gabriela
Garzón, Sebastián
González García, María-Esther
Pérez Persona, Ernesto
González-Calle, Verónica
Sirvent Auzmendi, Maialen
Arguiñano, José M.
González Montes, Yolanda
Ríos Tamayo, Rafael
Miguel Llorente, Dunia de
Palomera, Luis
Sampol, Antonia
Couto, María del Carmen
Grande, Marta
Fernández-Nistal, Alonso
Naves, Andrea
Ocio, Enrique M.
author_role author
author2 Montes, Carmen
Bustamante, Gabriela
Garzón, Sebastián
González García, María-Esther
Pérez Persona, Ernesto
González-Calle, Verónica
Sirvent Auzmendi, Maialen
Arguiñano, José M.
González Montes, Yolanda
Ríos Tamayo, Rafael
Miguel Llorente, Dunia de
Palomera, Luis
Sampol, Antonia
Couto, María del Carmen
Grande, Marta
Fernández-Nistal, Alonso
Naves, Andrea
Ocio, Enrique M.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Takeda Pharmaceutical Company
Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]
dc.subject.none.fl_str_mv Multiple myeloma
Relapsed/refractory multiple myeloma
Quality of life
Health‐related quality of life
EORTC QLQ-MY20 assessment
Burden of the disease
topic Multiple myeloma
Relapsed/refractory multiple myeloma
Quality of life
Health‐related quality of life
EORTC QLQ-MY20 assessment
Burden of the disease
description We evaluated the psychometric properties of the Spanish version of the European Organization for Research and Treatment of Multiple Myeloma (MM) specific quality-of-life (QoL) questionnaire module (QLQ-MY20) in relapsed/refractory MM (RRMM) patients. This was an observational, cross-sectional, multicenter study using EORTC QLQ-C30 and QLQ-MY20 in RRMM patients (ClinicalTrials.gov ID NCT03188536). We assessed the non-response rate, ceiling/floor effects, internal consistency, test-retest reliability, and validity. The study included 276 patients (53.3% males, mean [SD] age of 67.4 [10.5] years). The EORTC QLQ-MY20 showed a low non-response rate, very low ceiling and floor effects, and good internal consistency. The test-retest reliability assessment revealed good temporary stability, the construct validity analysis stated four main factors similar to the ones of the original version, and the criterion validity assessment showed no differences between groups. In conclusion, the Spanish version of EORTC QLQ-MY20 is a reliable and valid tool for assessing QoL in RRMM patients.
publishDate 2023
dc.date.none.fl_str_mv 2023
2024
2024
2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_6501
Publisher's version
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10261/346960
url http://hdl.handle.net/10261/346960
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv The underlying dataset has been published as supplementary material of the article in the publisher platform at 10.1080/10428194.2023.2240922
http://dx.doi.org/10.1080/10428194.2023.2240922

dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Taylor & Francis
publisher.none.fl_str_mv Taylor & Francis
dc.source.none.fl_str_mv reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC
instname:Consejo Superior de Investigaciones Científicas (CSIC)
instname_str Consejo Superior de Investigaciones Científicas (CSIC)
reponame_str DIGITAL.CSIC. Repositorio Institucional del CSIC
collection DIGITAL.CSIC. Repositorio Institucional del CSIC
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869425421874888704
score 15,811543